Regulation of Osteoblast Differentiation and Function by Connexin 43

连接蛋白 43 对成骨细胞分化和功能的调节

基本信息

  • 批准号:
    9022410
  • 负责人:
  • 金额:
    $ 32.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-03-01 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Diseases of low bone mass, like age-dependent osteoporosis, have a profound impact on society. Current therapies for the restoration or maintenance of bone mass are limited and focus primarily on the attenuation of osteoclast activity. The gap junction protein connexin 43, which permits the direct cell-to-cell communication of signals between osteoblasts and osteocytes, has been shown to play an important role in osteoblast/osteocyte function and the acquisition of peak bone mass. Despite the clear importance of connexin 43 in skeletal function, key molecular details of how connexin 43 regulates bone mass acquisition, osteoblast differentiation and osteoblast/osteocyte function are unknown. Rational therapies to impact skeletal diseases, like osteoporosis, cannot be designed without understanding the underlying molecular mechanisms affecting bone mass acquisition. Indeed, any intervention intended to impact the entire bone forming unit to reverse or slow down skeletal diseases will require an understanding of the intricate methods of intercellular exchange of information, such as those afforded by connexin 43, among osteoblasts and osteocytes for optimal efficacy. In this grant application, we hypothesize that connexin 43 regulates osteogenic differentiation and function, and ultimately bone quality, by regulating the recruitment and activation of signal transduction cascades that converge upon the master regulators of osteoblastogenesis, Runx2 and Osterix. This grant has two specific aims to address this hypothesis. (Specific Aim 1) To determine the contribution of Cx43 and Cx43-dependent signaling to osteogenic differentiation at the level of Runx2 and/or Osterix; (Specific Aim 2) To determine the requirements for both signal complex recruitment to connexin 43 and second messenger permeability by connexin 43 for downstream modulation of osteogenic differentiation and signaling. We will use cell and molecular biology, as well as in vivo genetic models to resolve key knowledge gaps, regarding how connexin 43 regulates bone. By defining these mechanisms, we will gain critical understanding of how connexin 43 ultimately affects osteoblast function and bone mass acquisition. Indeed our long-term goal is to apply the knowledge gleaned from these studies to modulate connexin 43 expression or connexin 43-dependent signaling cascades, either physiologically or pharmacologically, to increase bone mass acquisition to prevent or treat diseases of skeletal fragility. Indeed, understanding the coordination of osteoblast, osteocyte and osteoclasts networks is vital to the understanding nearly all diseases of skeletal metabolism.
描述(由申请人提供):低骨量疾病,如年龄依赖性骨质疏松症,对社会有深远的影响。目前用于恢复或维持骨量的疗法是有限的,并且主要集中在破骨细胞活性的减弱上。差距连接蛋白43允许成骨细胞和骨细胞之间的信号的直接细胞间通信,已显示在成骨细胞/骨细胞功能和峰值骨量的获得中起重要作用。尽管连接蛋白43在骨骼功能中具有明确的重要性,但连接蛋白43如何调节骨量获得、成骨细胞分化和成骨细胞/骨细胞功能的关键分子细节尚不清楚。如果不了解影响骨量获得的潜在分子机制,就无法设计影响骨骼疾病(如骨质疏松症)的合理疗法。事实上,任何旨在影响整个骨形成单位以逆转或减缓骨骼疾病的干预措施都需要了解成骨细胞和骨细胞之间复杂的细胞间信息交换方法,例如连接蛋白43提供的信息交换方法,以获得最佳疗效。在这项授权申请中,我们假设连接蛋白43通过调节信号转导级联的募集和激活来调节成骨细胞分化和功能,并最终调节骨质量,这些信号转导级联聚集在成骨细胞生成的主调节因子Runx 2和Osterix上。这项赠款有两个具体目标来解决这一假设。(具体目的1)确定Cx43和Cx43依赖性信号传导在Runx 2和/或Osterix水平对成骨分化的贡献;(具体目的2)确定信号复合物募集到连接蛋白43和连接蛋白43的第二信使渗透性对于成骨分化和信号传导的下游调节的要求。我们将使用细胞和分子生物学,以及体内遗传模型来解决关键的知识缺口,关于连接蛋白43如何调节骨。通过定义这些机制,我们将获得关键的理解,连接蛋白43如何最终影响成骨细胞的功能和骨量收购。事实上,我们的长期目标是应用从这些研究中收集的知识来调节连接蛋白43的表达或连接蛋白43依赖性信号级联,无论是生理上的还是骨代谢上的,以增加骨量获得来预防或治疗骨骼脆弱性疾病。事实上,了解成骨细胞,骨细胞和破骨细胞网络的协调是至关重要的了解几乎所有的骨骼代谢疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph P. Stains其他文献

Characterization of a pollen-expressed gene encoding a putative pectin esterase ofPetunia inflata
  • DOI:
    10.1007/bf00043881
  • 发表时间:
    1994-06-01
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Jing-Hong Mu;Joseph P. Stains;Teh-hui Kao
  • 通讯作者:
    Teh-hui Kao
Microtubule Remodeling Contributes to the Loss of Force and Power in Aging Skeletal Muscle
  • DOI:
    10.1016/j.bpj.2019.11.2740
  • 发表时间:
    2020-02-07
  • 期刊:
  • 影响因子:
  • 作者:
    Humberto Cavalcante Joca;Anicca Harriot;Jenna Leser;Andrew Coleman;Guoli Shi;Joseph P. Stains;Christopher W. Ward
  • 通讯作者:
    Christopher W. Ward
Microtubule Mechanotransduction through Nox2-ROS Initiates TRPV4 Calcium Influx and Purinergic Calcium Oscillations that Regulate Osteocyte Mechano-Sensing
  • DOI:
    10.1016/j.bpj.2018.11.2041
  • 发表时间:
    2019-02-15
  • 期刊:
  • 影响因子:
  • 作者:
    Katrina M. Williams;Nicole Gould;Derek Jones;Ramzi Khairallah;Christopher W. Ward;Joseph P. Stains
  • 通讯作者:
    Joseph P. Stains
Increased Microtubule Density and Level of Detyrosination Occur Coincident with Sarcomere Malformations in Diseased and Aging Skeletal Muscle
  • DOI:
    10.1016/j.bpj.2018.11.2188
  • 发表时间:
    2019-02-15
  • 期刊:
  • 影响因子:
  • 作者:
    Anicca Harriot;Andrew Coleman;Shama R. Iyer;Camilo Venagas;Guoli Shi;Richard M. Lovering;Humberto C. Joca;Joseph P. Stains;Chris W. Ward
  • 通讯作者:
    Chris W. Ward

Joseph P. Stains的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph P. Stains', 18)}}的其他基金

Mechanisms of osteocyte mechano-signaling and sclerostin regulation
骨细胞机械信号传导和硬化素调节机制
  • 批准号:
    10395929
  • 财政年份:
    2018
  • 资助金额:
    $ 32.62万
  • 项目类别:
Mechanisms of osteocyte mechano-signaling and sclerostin regulation
骨细胞机械信号传导和硬化素调节机制
  • 批准号:
    9922216
  • 财政年份:
    2018
  • 资助金额:
    $ 32.62万
  • 项目类别:
Regulation of Osteoblast Differentiation and Function by Connexin 43
连接蛋白 43 对成骨细胞分化和功能的调节
  • 批准号:
    9230816
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Spatial Control of Bone Remodeling by Gap Junction-Communicated cAMP
间隙连接通讯 cAMP 对骨重塑的空间控制
  • 批准号:
    10586047
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Regulation of Osteoblast Differentiation and Function by Connexin 43
连接蛋白 43 对成骨细胞分化和功能的调节
  • 批准号:
    8415654
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Spatial Control of Bone Remodeling by Gap Junction-Communicated cAMP
间隙连接通讯 cAMP 对骨重塑的空间控制
  • 批准号:
    9893064
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Spatial Control of Bone Remodeling by Gap Junction-Communicated cAMP
间隙连接通讯 cAMP 对骨重塑的空间控制
  • 批准号:
    10358565
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Regulation of Osteoblast Differentiation and Function by Connexin 43
连接蛋白 43 对成骨细胞分化和功能的调节
  • 批准号:
    8628047
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Regulation of Osteoblast Differentiation and Function by Connexin 43
连接蛋白 43 对成骨细胞分化和功能的调节
  • 批准号:
    8828565
  • 财政年份:
    2013
  • 资助金额:
    $ 32.62万
  • 项目类别:
Intercellular Signaling in Bone
骨中的细胞间信号传导
  • 批准号:
    7385084
  • 财政年份:
    2006
  • 资助金额:
    $ 32.62万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 32.62万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了